Human PBMCs: a powerful tool for your research

  • [Mar 02, 2021]

Human peripheral blood mononuclear cells (PBMCs) mainly consist of lymphocytes and monocytes and are a critical component of the body’s complex and dynamic immune system.
These cells serve as a powerful platform for a wide spectrum of research
and clinical studies related to human health and disease. Therefore,
PBMCs are not only used in immunological studies, vaccine development
or biomarker identification, but also in infectious disease research, toxicity screening, cancer immunotherapy and personalized medicine.

Your advantages with BIOMEX
Biomex is your sustainable source of purified, fresh or frozen human PBMCs.
We operate two own donor centers in Germany and maintain a large donor database to source samples according to your very specific requirements. This allows us to identify, preserve and reserve suitable donors for your projects.

Our active donor stock at a glance
    ◊  ≥ 400 healthy donors
    ◊  ≥ 300 donors with a broad range of active or convalescent infectious
        diseases, including SARS-CoV-2 mutation serotypes such
        as B.1.1.7 and B1.351
    ◊  demographics, medical history, disease characterization and
        outcome data
    ◊  a wide-ranging network of physicians to find donors with
        certain diseases

Characterization of PBMCs
    ◊  HLA Class- I/II typing
    ◊  Serological pathogen testing - large QC portfolio according to your
        requirements (e.g. anti-HIV-1/2, anti-HCV, HBsAg and
        microbial contaminants (fungi, bacteria, and mycoplasma))
    ◊  Functional characterization on demand

Highest quality in handling and storage
We can provide fresh and frozen PBMCs, both in FCS or in animal-free media – this includes same-day collection and sample shipment.
All of our cryopreserved PBMCs are stored within the vapor liquid nitrogen phase (< -150°C) per best practice. Custom handling and storage are available to meet your study needs.

Please contact us directly at to get feedback regarding your specific needs.

← back to news overview